146 related articles for article (PubMed ID: 6295690)
1. Platelet alpha 2-adrenergic receptors in treated and untreated essential hypertension.
Motulsky HJ; O'Connor DT; Insel PA
Clin Sci (Lond); 1983 Mar; 64(3):265-72. PubMed ID: 6295690
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of platelet alpha2 adrenergic receptors in a population of patients with essential arterial hypertension and in normotensive subjects].
Fabris B; Fischetti F; Bulli G; Giraldi T; Castellano M; Beschi MG; Carretta R
G Ital Cardiol; 1991 Jul; 21(7):717-23. PubMed ID: 1662651
[TBL] [Abstract][Full Text] [Related]
3. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
Motulsky HJ; Insel PA
Biochem Pharmacol; 1982 Aug; 31(16):2591-7. PubMed ID: 6291538
[TBL] [Abstract][Full Text] [Related]
4. Interaction of verapamil with human platelet alpha-adrenergic receptors.
Barnathan ES; Addonizio VP; Shattil SJ
Am J Physiol; 1982 Jan; 242(1):H19-23. PubMed ID: 6277203
[TBL] [Abstract][Full Text] [Related]
5. Influence of sodium on the alpha 2-adrenergic receptor system of human platelets. Role for intraplatelet sodium in receptor binding.
Motulsky HJ; Insel PA
J Biol Chem; 1983 Mar; 258(6):3913-9. PubMed ID: 6300062
[TBL] [Abstract][Full Text] [Related]
6. Characterization of alpha 2-adrenoceptors on blood platelets from various species using 3H-yohimbine.
Glusa E; Markwardt F
Haemostasis; 1983; 13(2):96-101. PubMed ID: 6307838
[TBL] [Abstract][Full Text] [Related]
7. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
Brodde OE; Daul A; O'Hara N; Bock KD
J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
[TBL] [Abstract][Full Text] [Related]
8. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
Lanza F; Cazenave JP
Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
[TBL] [Abstract][Full Text] [Related]
9. Plasma catecholamine modulation of alpha 2 adrenoreceptor agonist affinity and sensitivity in normotensive and hypertensive human platelets.
Hollister AS; Onrot J; Lonce S; Nadeau JH; Robertson D
J Clin Invest; 1986 May; 77(5):1416-21. PubMed ID: 3009543
[TBL] [Abstract][Full Text] [Related]
10. Alteration of platelet alpha 2-adrenoceptors in human hypertension.
Continsouza-Blanc D; Elghozi JL; Dausse JP
J Hypertens Suppl; 1984 Dec; 2(3):S155-7. PubMed ID: 6100735
[TBL] [Abstract][Full Text] [Related]
11. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
[TBL] [Abstract][Full Text] [Related]
12. Human platelet alpha 2-adrenoceptors: relationship between radioligand binding studies and adrenaline-induced aggregation in normal individuals.
Swart SS; Pearson D; Wood JK; Barnett DB
Eur J Pharmacol; 1984 Aug; 103(1-2):25-32. PubMed ID: 6090177
[TBL] [Abstract][Full Text] [Related]
13. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
Mukherjee A
Biochim Biophys Acta; 1981 Aug; 676(2):148-54. PubMed ID: 6114754
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic receptors in human and experimental pheochromocytoma.
Snavely MD; Motulsky HJ; O'Connor DT; Ziegler MG; Insel PA
Clin Exp Hypertens A; 1982; 4(4-5):829-48. PubMed ID: 6286177
[TBL] [Abstract][Full Text] [Related]
15. Platelet alpha2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol.
Portaluppi F; Manfredini R; Varani K; Gessi S; Caiazza A; Borea PA
J Hypertens; 2000 Feb; 18(2):217-21. PubMed ID: 10694191
[TBL] [Abstract][Full Text] [Related]
16. Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.
Newman KD; Williams LT; Bishopric NH; Lefkowitz RJ
J Clin Invest; 1978 Feb; 61(2):395-402. PubMed ID: 23392
[TBL] [Abstract][Full Text] [Related]
17. Alpha 2-adrenoceptors in platelets of spontaneously hypertensive rats.
Minuth M; Jakobs KH
Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):98-103. PubMed ID: 6135162
[TBL] [Abstract][Full Text] [Related]
18. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients.
Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C
J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853
[TBL] [Abstract][Full Text] [Related]
19. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
Gerhardt MA; Wade SM; Neubig RR
Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
[TBL] [Abstract][Full Text] [Related]
20. alpha 2-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle.
Jones SB; Bylund DB; Rieser CA; Shekim WO; Byer JA; Carr GW
Clin Pharmacol Ther; 1983 Jul; 34(1):90-6. PubMed ID: 6305547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
